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Preamble
It is becoming more apparent each day that despite a
strong national commitment to excellence in health care,
the resources and personnel are finite. It is, therefore, ap-
propriate that the medical profession examine the impact of
developing technology on the practice and cost of medical
care. Such analysis, carefully conducted, could potentially
impact on the cost of medical care without diminishing the
effectiveness of that care.
To this end, the American College of Cardiology and
the American Heart Association in 1980 established a Task
Force on Assessment of Diagnostic and Therapeutic Car-
diovascular Procedures with the following charge:
The Task Force of the American College of Cardiology and
the American Heart Association shall define the role of
specific noninvasive and invasive procedures in the
diagnosis and management of cardiovascular disease.
The Task Force shall address, when appropriate, the
contribution, uniqueness, sensitivity, specificity.
indications, contraindications and cost-effectiveness of
such specific procedures.
Address for reprints: Me. David J. Feild. Associate Executive Vice
President. American College ofCardiology, 9111 Old Georgetown Road,
Bethesda, Maryland 20814.
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The Task Force shall include a Chairman and four members,
two representatives from the American Heart Association
and two representatives from the American College of
Cardiology. The Task Force may select ad hoc members
as needed upon the approval of the Presidents of both
organizations.
Recommendations of the Task Force are forwarded to the
President of each organization.
The members of the Task Force are: Roman W. De-
Sanctis, MD, Harold T. Dodge, MD, T. Joseph Reeves,
MD, Sylvan Lee Weinberg, MD and Charles Fisch, MD,
Chairman.
The Subcommittee on Coronary Angiography was chaired
by John Ross, Jr., MD, and included the following mem-
bers: Robert O. Brandenburg, MD, Robert E. Dinsmore,
MD, Gottleib C. Friesinger II, MD, Herbert H. Hultgren,
MD, Carl J. Pepine, MD, Elliot Rapaport, MD, Thomas J.
Ryan, MD, Sylvan Lee Weinberg, MD and John F. Wil-
liams, r-.. MD.
This document was reviewed by the officers and other
responsible individuals of the two organizations and re-
ceived final approval in March 1987. It is being published
simultaneously in Circulation and Journal of the American
College of Cardiology. The potential impact of this docu-
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ment on the practice of cardiology and some of its una-
voidable shortcomings are clearly set out in the introduction.
Charles Fisch, MD, FACC
I. Introduction
The American College of Cardiology/American Heart
Association Task Force on Assessment of Cardiovascular
Procedures was formed to make recommendations regarding
appropriate utilization of technology in the diagnosis and
treatment of patients with cardiovascular disease. Coronary
angiography is one such important technique. The uses of
coronary angiography have undergone an extraordinary ex-
pansion in the recent past, in part stimulated by the devel-
opment of improved techniques and new forms of treatment,
particularly for patients with atherosclerotic coronary heart
disease. This has led to some expansion of the indications
for coronary angiography, and in some settings overuse of
this procedure has been suggested. Accordingly, it was rec-
ommended that this Task Force review current indications
and develop guidelines for the use of coronary angiography.
Recommendations concerning the staffing and equipment
of laboratories are beyond the scope of this report, and
statements concerning the safety of outpatient cardiac cath-
eterization procedures are available (I). The guidelines pro-
vided may contribute to limiting overuse of coronary an-
giography, and it is considered that the proportion of studies
in a given laboratory that show entirely normal coronary
arteriograms or one or more coronary stenoses of <50%
diameter should not exceed approximately 25%.*
This report is not intended to provide strict indications
or contraindications to coronary angiography because, in
the individual patient, multiple other considerations may be
relevant, including the family setting, occupational needs
and individual preferences concerning life-style. Rather, the
report is intended to provide general guidelines that may be
helpful to the practitioner, as well as to various health care
agencies.
The primary purpose of coronary angiography is to de-
fine the anatomy of the coronary arteries when such infor-
mation is needed for patient management. This anatomic
definition includes assessment of the presence, extent and
severity of obstructive atherosclerotic coronary artery dis-
ease, coronary artery size, coronary collateral flow, throm-
bus formation, dynamic obstructions (coronary spasm) or
congenital coronary artery anomalies.
Coronary angiography is the only method currently avail-
able for defining the details of vascular anatomy in the
coronary arteries, and as such it provides the reference stan-
dard against which less direct methods for studying the
*Based on the registry of over 20,000 studies in a large multicenter
trial (Coronary Artery Surgery Study) in which somewhat less than 20%
of the population undergoing coronary angiography had a normal or near
normal study (2).
coronary circulation are judged. Therefore, although it is a
relatively expensive procedure, its "cost-effectiveness"
cannot be directly compared with other approaches at this
time.t
Coronary angiography is used not only in diagnosis but
also to assess the appropriateness and feasibility of various
forms of therapy aimed directly at the coronary arteries,
such as percutaneous coronary angioplasty, coronary artery
bypass surgery, thrombolysis or treatments designed to cause
regression of atherosclerosis. Finally, information provided
by coronary angiography is useful for assessing the results
of therapy and in helping to formulate prognosis in patients
with coronary artery disease. It should be emphasized that
coronary angiography does not provide direct information
about the patient's functional capacity and symptoms or the
functional significance of a given coronary lesion. More-
over, prognosis has multiple determinants not discernible
at angiography which are often key issues in clinical decision
making.
The format of this report includes, first, some general
considerations concerning the accuracy of coronary angi-
ography, contraindications to its use, and risks of the pro-
cedure. The applications ofcoronary angiography in specific
disease states are then presented and briefly discussed.
II. General Considerations
A. Accuracy of Coronary Angiography
Coronary angiography continues to be the standard for
assessing coronary artery obstructive disease, but some lim-
itations of the technique are important to recognize. Con-
ventionally, the degree of coronary artery obstruction is
estimated as the percent reduction of luminal diameter, de-
termined by comparing the diameter at the site of maximal
reduction to that in adjacent areas that appear either normal
or only minimally diseased. This conventional approach has
been clinically useful and is the one most widely applied.
Nevertheless, there is significant interobserver variability in
the conventional interpretation of coronary artery obstruc-
tions, and quantitative techniques that substantially reduce
interobserver variability are sometimes used (3-5), includ-
ing application of digital subtraction angiography (6) to-
gether with automated techniques that employ manual or
computerized border detection or video densitometry. Some
digital techniques currently are in use in clinical practice,
but application of these promising approaches is not yet
widespread.
Some studies have suggested that when the degree of
obstruction assessed by coronary angiography is compared
with that found at postmortem examination, significant
tOutpatient cardiac catheterization in association with techniques for
assessing the functional significance of coronary lesions is an emerging
approach that may improve cost-effectiveness in the future.
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underestimation of atherosclerosis by coronary angiography
can occur (7,8). However, quantitative study of coronary
obstructions when postmortem coronary angiography is per-
formed with the arteries fixed at physiologic intraluminal
pressures shows excellent agreement with direct postmortem
measurements (3). It should be noted that postmortem stud-
ies, in contrast to coronary angiography, do not detect changes
in coronary caliber due to altered coronary vascular smooth
muscle tone or to thrombus that has undergone spontaneous
lysis.
Techniques to estimate coronary flow reserve from peak
coronary flow velocity during reactive hyperemia suggest
that minimal absolute coronary stenosis diameter correlates
better than the percent diameter reduction with the functional
importance of the stenosis (9,10), This finding may relate
to unrecognized diffuse narrowing of so-called normal coro-
nary artery segments.
B. Contraindications to Coronary Angiography
All contraindications are relative and best considered by
determining whether or not coronary angiography is needed
in an emergency or elective setting. In an emergency setting,
information obtained by coronary angiography can be life-
saving and there may be no contraindications. Examples of
such emergency settings are acute myocardial infarction in
a candidate for revascularization therapy; mechanical com-
plication early after myocardial infarction that cannot be
managed using medical therapy (such as suspected ventric-
ular septal defect or papillary muscle rupture), the presence,
in some patients, of unstable angina refractory to medical
management, suspected severe aortic stenosis in the patient
with refractory heart failure or myocardial ischemia, acute
aortic root dissection associated with myocardial ischemia
or emergency assessment of a prospective cardiac transplant
donor.
Relative Contraindications:
a. Recent stroke (within I month)
b. Progressive renal insufficiency
c. Active gastrointestinal bleeding
d. Fever which may be due to infection
e. Active infection
f. Short life expectancy due to other illnesses such
as cancer or severe pulmonary, hepatic or renal
disease
g. Severe anemia
h. Severe uncontrolled systemic hypertension
i. Severe electrolyte imbalance
j. Severe systemic or psychologic illness in which
prognosis is doubtful or behavior is unpredictable
producing undue risk of cardiac catheterization
k. Very advanced physiologic (not chronologie) age
1. Patient refusal to consider definitive treatment such
as angioplasty, coronary artery bypass surgery or
valve replacement
rn. In patients in unstable condition, lack of a cardiac
surgical team in the hospital (such patients refrac-
tory to maximal medical therapy should generally
be transferred to a center where surgical backup
is immediately available). Under special circum-
stances, when the condition of a hospitalized pa-
tient can be readily stabilized such as by use of
balloon counterpulsation, coronary angiography
might be undertaken in the hospital in the absence
of a cardiac surgical team provided that well de-
fined mechanisms are in place for rapid referral
and acceptance of such patients by a hospital in
which emergency surgery or angioplasty can be
carried out with minimal delay*
n. Digitalis intoxication
o. Documented anaphylaxis during previous expo-
sure to angiographic contrast material; in most pa-
tients with a history of an immediate generalized
anaphylactoid reaction to contrast material, the re-
actions do not constitute anaphylaxis and these
individuals can safely undergo coronary angiog-
raphy using premedication with corticosteroids and
antihistamines (11)
It should be recognized that most of these conditions may
be temporary or reversible, allowing relatively safe cathe-
terization when the condition is corrected or stabilized,
C. Risks of Coronary Angiography
Overall, coronary angiography is, and should be, very
safe. The risk to life should average <0.2%, and the risk
of major adverse effects (for example, stroke, myocardial
infarction or major bleeding) should be <0.5% (12). How-
ever, certain groups at higher risk can be identified before
catheterization or on visualization of the coronary arteries.
These individuals often have increased risk predicted by
exercise testing (13) (for example, abnormal blood pressure
response or >2 mm of ST segment depression in multiple
leads at a relatively low heart rate). Other characteristics of
increased risk for complications during coronary angiog-
raphy include patients with critical left main coronary ste-
nosis, severe three vessel disease (>90% stenosis in each
of three vessels), multivessel disease with left ventricular
dysfunction (ejection fraction :::::35%), critical aortic valve
stenosis and advanced age (14). Despite higher risk of com-
plications in some patients, the risk/benefit ratio may be
"This statement is in no way intended to change current policy of the
American College of Cardiology and the American Heart Association,
published in Circulation (Vol. 73, No.3, p. 21, 1986) which states that
"The ACC and the AHA do not approve the use of free-standing, non-
hospital based cardiac catheterization laboratories."
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favorable and the information obtained from the study re-
quired to make an appropriate decision.
D. Associated Procedures
A number of associated procedures are often performed
in association with coronary angiography, as described in
Appendix A. These include a venous line and hemodynamic
measurements in the aorta and left ventricle. Left ventric-
ulography is normally a part of coronary angiography, al-
though it may be excluded in certain high risk patients if
reliable noninvasive methods of assessing left ventricular
function are available. Other associated procedures that are
sometimes but not routinely required include right heart
catheterization, placement of a temporary pacemaker, se-
lective internal mammary artery angiography, vein bypass
graft angiography, aortic root angiography and a variety of
transcatheter procedures such as coronary angioplasty (see
Appendix A).
III. Classification of Applications of
Coronary Angiography
In considering the use of coronary angiography in specific
disease states, the following classification is used throughout
this report:
Class I: Conditions for which there is general agreement
that coronary angiography is justified. A Class I indication
should not be taken to mean that coronary angiography is
the only acceptable diagnostic procedure.
Class II: Conditions for which coronary angiography is
frequently performed, but there is a divergence of opinion
with respect to its justification in terms of value and appro-
priateness.
Class III: Conditions for which there is general agree-
ment that coronary angiography is not ordinarily justified.
Specific disease states are considered under the following
categories: known or suspected coronary heart disease, atyp-
ical chest pain, acute myocardial infarction, valvular heart
disease, congenital heart disease and other conditions.
It is recognized that the field of coronary angiography is
undergoing considerable change, and as new insights are
gained we can anticipate further refinement of the guidelines
for coronary angiography set forth in this document.
IV. Known or Suspected Coronary
Heart Disease
A. Asymptomatic Patients
Asymptomatic patients with known coronary artery dis-
ease generally are those who have had a previous myocardial
infarction or have undergone coronary bypass surgery or
angioplasty (asymptomatic patients within 8 weeks of an
acute myocardial infarction are considered under VI).
Asymptomatic patients with suspected coronary artery dis-
ease generally are those who have rest or exercise-induced
electrocardiography (ECG) abnormalities suggesting "silent
myocardial ischemia," often associated with other risk fac-
tors.
Class I
I. Evidence of high risk* on noninvasive testing.
a. Exercise ECG testing
Abnormal horizontal or downsloping
ST segment depression:t
Onset at heart rate <120/min (off beta-blockers)
or :s6.5 METSt
Magnitude ::::::2.0 mm of depression
Postexercise duration ::::::6 minutes
Depression in multiple leads
Abnormal systolic blood pressure response during
progressive exercise:§
With sustained decrease of > 10 mm Hg or flat
blood pressure response (:s 130 mm Hg), as-
sociated with ECG evidence of ischemia
Other potentially important determinants
Exercise-induced ST segment elevation in leads
other than aVR
Exercise-induced ventricular tachycardia
b. Thallium scintigraphy
Abnormal thallium distribution in more than one
vascular region at rest or with exercise, or abnor-
mal distribution (ischemia) associated with in-
creased lung uptake produced by exercise in the
absence of severely depressed left ventricular func-
tion at rest.
c. Radionuclide ventriculography
A fall in left ventricular ejection fraction of ::::::0.10
during exercise, or a rest or exercise left ventricular
ejection fraction of <0.50, when suspected to be
due to coronary artery disease.
2. In individuals whose occupation involves the safety
of others, for example, airline pilots, bus drivers, truck
drivers, air traffic controllers. Also, those in certain
occupations that frequently require sudden vigorous
*High risk patients generally are those with reduced life expectancy
due to left main or multivessel coronary artery disease. often with impaired
left ventricular function.
tExcept for patients with ST segment depression at rest. intraventricular
conduction defects excluding right bundle branch block. electrolyte ab-
normalities and those receiving certain drugs such as a digitalis glycosides,
who frequently develop ST segment depression suggestive of ischemia
during exercise testing. Recommendations in this section based on ECG
criteria during exercise may not apply if these conditions are present.
:j:Energy expenditure at rest, equivalent to an oxygen uptake of ap-
proximately 3.5 ml 02/kg body weight per min.
§A decline in systolic blood pressure may occur in some patients
without heart disease during sustained maximal exercise. or if certain
medications are in use at the time of the exercise test.
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activity, for example, firefighters, police officers, ath-
letes.
3. After successful resuscitation from cardiac arrest that
occurred without obvious precipitating cause when a
reasonable suspicion of coronary artery disease exists.
Class II
I. The presence of :::::1 but <2 mm of ischemic ST
depression during exercise, confirmed as ischemia by
an independent noninvasive stress test (radionuclide
thallium or ventriculographic study, or two-dimen-
sional echocardiographic study, but without criteria
for high risk as listed in Class I, Ib and Ie).
2. The presence of two or more major risk factors* and
a positive exercise test in male patients without known
coronary heart disease.
3. The presence of prior myocardial infarction with nor-
mal left ventricular function at rest and evidence of
ischemia by noninvasive testing, but without high risk
criteria (Class 1,1).
4. After coronary bypass surgery or percutaneous trans-
luminal angioplasty when there is evidence of isch-
emia by noninvasive testing.
S. Before high risk noncardiac surgery] in patients who
have evidence of ischemia by noninvasive testing.
6. Periodic evaluation of patients after cardiac trans-
plantation.
Class III
I. As a screening test for coronary artery disease in pa-
tients who have not had appropriate noninvasive test-
mg.
2. After coronary bypass surgery or percutaneous trans-
luminal angioplasty when there is no evidence of isch-
emia, unless with informed consent for research pur-
poses.
3. The presence of an abnormal ECG exercise test alone,
excluding the categories listed in Classes I and II.
B. Symptomatic Patients
Symptoms are defined in accordance with the Canadian
Cardiovascular Society classification (Appendix B).
Class I
I. Angina pectoris that has proved inadequately respon-
sive to medical treatment, percutaneous transluminal
angioplasty thrombolytic therapy or coronary bypass
surgery. "Inadequately responsive" is taken to mean
that patient and physician agree that angina signifi-
cantly interferes with a patient's occupation or ability
to perform his or her usual activities.
*Smoking. hypertension. hypercholesterolemia. positive family his-
tory. diabetes mellitus.
tFor example, carotid endarterectomy, abdominal or thoracic aneu-
rysmectomy. ileofemoral bypass surgery.
2. Unstable angina pectoris
a. Acceleration with increased severity and frequency
of chronic angina pectoris within the past 2 months,
despite medical management, including onset of
angina at rest.
b. New onset (within 2 months) of angina pectoris
which is severe or increases despite medical treat-
ment.
c. Acute coronary insufficiency, with pain at rest usu-
ally of :::::15 minutes' duration, associated with ST-
T wave changes, within the preceding 2 weeks.
3. Prinzmetal's or variant angina pectoris
4. Angina pectoris (even of Canadian Cardiovascular So-
ciety class I or II severity, see Appendix B) in asso-
ciation with any of the following:
a. Evidence of high risk as manifested by:
Exercise ECG testing
In addition to high risk findings listed in section
IVA, Class I, la: failure to complete stage II of
Bruce protocol or equivalent work load (:56.5 METS
with other protocols; see METS definition under
section IV, Class I, la) due to ischemic cardiac
symptoms. Exercise heart rate at onset of limiting
ischemic symptoms of < 120/min (off beta-block-
ers).
Radionuclide exercise testing (see section IVA,
Class I, Ib and Ie).
b. The coexistence of a history of myocardial infarc-
tion, a history of hypertension and ST segment
depression on the baseline ECG.
c. Intolerance to medical therapy because of uncon-
trollable side effects.
d. An occupation or lifestyle that involves unusual
risk, or "need to know" for insurance or job-
related purposes (see section IVA, Class I, 2).
e. Episodic pulmonary edema or symptoms of left
ventricular failure without obvious cause.
S. Before major vascular surgery, such as repair of an
aortic aneurysm, ileofemoral bypass or carotid artery
surgery, if angina pectoris is present or there is ob-
jective evidence of myocardial ischemia.
6. After resuscitation from cardiac arrest (ventricular fi-
brillation or standstill) or from sustained ventricular
tachycardia in the absence of acute myocardial in-
farction.
Class II
I. Angina pectoris (even of Canadian class I or II se-
verity) in the following groups:
a. Female patients <40 years of age with objective
evidence of myocardial ischemia by noninvasive
testing.
b. Male patients <40 years of age.
c. Patients <40 years of age with previous myo-
cardial infarction.
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d . Patients requiring major nonvascular surgery (in-
traabdominal, intrathoracic , and so on) if there is
objective evidence of myocardial ischemia.
e. Patients who show a progressively more abnormal
exercise ECG or other noninvasive stress test on
serial testing.
2. the presence of Canadian class III or IV angina which,
with medical management, changes to class I or II
when other studies suggest absence of high risk (see
section IVA, Class I, I) .
3 . Patients who cannot be risk stratified by other means;
for example, those unable to exercise because of am-
putation, arthritis, limb deformity or peripheral vas-
cular disease.
Class III
I. The presence of mild, clinically stable (Canadian class
I or II) angina pectoris in patients who do not have
impaired ventricular function, or exercise studies sug-
gesting high risk (see section IVA, Class I, I) or other
criteria listed under Class I and II.
2. The presence of well controlled angina pectoris (Ca-
nadian class I or II) in patients who are clearly not
candidates for bypass surgery or angioplasty because
of age or life expectancy limited by other illnesses
(for example, cancer). In these patients, age is taken
to mean biologic age rather than chronologie age and
in most instances would be approximately 80 years of
age .
Comments
It is generally agreed that whether Ornot angina pectoris
is present:
I. The existence or absence of coronary artery disease should
be established with reasonable probability in patients in
whom coronary artery disease is suspected.
2. Patients with coronary artery disease who are at high
risk for future cardiac events should be identified.
High risk patients generally are those likely to have re-
duced life expectancy due to left main or multivessel disease
and ischemia. particularly if these are accompanied by im-
paired left ventricular function . The performance of coro-
nary angiography in all patients, whether symptomatic or
asymptomatic, with known or suspected coronary artery
disease clearly would be very costly . Noninvasive tests,
including exercise ECG testing and radionuclide myocardial
imaging or ventriculography, are of value for detecting pa-
tients with suspected coronary artery disease, as well as for
identifying patients who are at high risk, and they are con-
siderably less costly than coronary angiography. However,
it is not clear at present whether the use of these noninvasive
tests in screening for the detection of severe ischemia and
high risk is more or less cost-effective than coronary an-
giography alone . Of course, coronary angiography alone
cannot always ascertain the functional significance of coro-
nary stenoses . In the absence of definitive cost-effectiveness
data. our recommendations are based on the demonstrated
value of the proposed noninvasive tests as screening pro-
cedures for identifying induced ischemia and high risk pa-
tients .
The criteria cited above for high risk during exercise ECG
testing have been stated in a joint ACCIAHA Task Force
report (13). which also emphasized the difficulties in inter-
preting ECG changes in women with a low pretest likelihood
of disease. Also, it should be noted that the majority of
apparently healthy men who have a positive exercise ECG
test (without high risk criteria), and who lack other risk
factors, do not have significant coronary artery disease (15).
Radionuclide techniques have higher specificity than the
exercise ECG for detecting the presence of coronary artery
disease and are of value in detecting multivessel coronary
artery disease , as summarized in the ACCIAHA Guidelines
for Clinical Use of Cardiac Radionuclide Imaging (16) .
Patients with coronary artery disease and defects on exer-
cise-thallium imaging in more than one vascular area, or
with redistribution (ischemia) and increased lung uptake are
at increased risk (16). Patients at increased risk also can be
identified by radionuclide ventriculography that demon-
strates a left ventricular ejection fraction < 0.50 at rest,
decreases :2: 10% with exercise or fails to exceed 0.50 during
exercise particularly in association with new or worsening
regional wall motion abnormalities during exercise (16) .
Because none of the noninvasive techniques are 100%
sensitive and specific. coronary angiography is indicated in
those patients whose occupation or lifestyle requires that
the presence or absence of coronary artery disease be es-
tablished with certainty (see section IVA, Class I, 2).
Asymptomatic patients
In addition to its use as a diagnostic tool to establish or
exclude coronary artery disease, coronary angiography is
also used to guide therapy , that is, the selection of medical
or surgical treatment. However, therapeutic recommenda-
tions in asymptomatic patients based on the extent of coro-
nary artery disease generally are derived from studies in
which the majority of patients had had a previous myocardial
infarction (17-20) . Furthermore , data from the Coronary
Artery Surgery Study, which included both asymptomatic
and mildly symptomatic patients without left main coronary
artery disease, indicate that only those patients with left
ventricular dysfunction-that is, ejection fraction between
0.35 and O.50-and triple vessel disease demonstrated in-
creased longevity after coronary artery bypass surgery (21) .
The prognosis of asymptomatic patients without previous
myocardial infarction should be as good as, if not better
than, that of patients with infarction (22), and in the latter
the 5 year mortality rate with medical therapy is approxi-
mately 2.4%/year (17). The few prospective data available
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in apparently healthy subjects with silent ischemia and an-
giographically proved coronary artery disease indicate that
the 8 year mortality rate is approximately 1.5%/year (23),
a figure comparable with the long-term mortality after by-
pass surgery.
There is varying opinion as to when coronary angiog-
raphy should beperformed in asymptomatic patients in whom
noninvasive testing indicates a high probability of coronary
artery disease, but who are not at high risk as defined by
noninvasive test criteria. In part. this is attributable to the
observation that the development of ischemia during exer-
cise testing, other than the high risk type, does not itself
indicate a poor prognosis (24). yet a small proportion of
patients with left main or severe rnultivessel coronary artery
disease will not be detected by noninvasive techniques. It
is in the ostensibly non-high risk group that other factors
such as age. occupation or life-style become increasingly
important considerations when determining whether coro-
nary angiography should be performed.
Adult patients successfully resuscitated from cardiac ar-
rest generally have extensive coronary artery disease. In the
absence of recognized precipitating factors. such as acute
myocardial infarction. these patients are at high risk for
recurrent cardiac arrest (25). and coronary angiography is
of value in determining the underlying cause and planning
the most appropriate therapeutic approach.
Patients with peripheral vascular disease frequently have
coronary artery disease. which results in considerable mor-
bidity and mortality when they undergo high risk. noncar-
diac surgery, such as abdominal aneurysmectomy or carotid
endarterectomy. Some have advocated routine coronary an-
giography for all patients undergoing peripheral vascular
surgery (26), but others have demonstrated that such patients
can undergo surgery without significant risk of perioperative
infarction if they do not have angina or prior infarction (27) .
Initial studies show that patients who have normal thallium
distribution during intravenous dipyridamole infusion rarely
have a perioperative infarction after peripheral vascular sur-
gery, even if coronary artery disease is present (28). In
patients with ischemia induced by exercise or other means,
definition of the extent of the coronary artery disease by
coronary angiography is important in assessing operative
risk and determining the need for coronary revascularization
before the noncardiac surgery.
Symptomatic patients
In patients with angina pectoris, recent studies suggest
that the severity of angina often does not predict prognosis
(29), although patients with very severe angina pectoris
(Canadian classes III and IV) have been found to have a
better outlook with surgical than with medical treatment
(30). Furthermore, there is no relation between the fre-
quency of exertional or rest pain and either the severity of
coronary artery disease or the frequency of ischemic epi-
sodes documented by continuous ECG recordings (31).
Symptoms are often widely variable from patient to patient
and even in the same patient. Accordingly, symptom relief
by therapy will also vary widely from patient to patient.
For these reasons. given the same case histories, physicians
in different practice settings vary widely in their assessment
of the proper timing for coronary angiography (32). There-
fore, in this report we frequently emphasize use of nonin-
vasive measures of high risk rather than symptoms alone in
deciding on the timing of coronary angiography.
Acute pulmonary edema, in the absence of acute myo-
cardial infarction, in patients with coronary heart disease
carries a poor prognosis and is usually associated with ab-
normal left ventricular function (33). Some patients with
recurrent pulmonary edema due to myocardial ischemia have
adequate left ventricular systolic function and may be ben-
efited by coronary artery bypass surgery (34).
Other clinical data may also be useful in assessing risk,
and the coexistence of three or more findings (history of
myocardial infarction, history of hypertension. ST segment
depression on the rest ECGand New York Heart Association
functional class III or IV) were found to identify high risk
patients in the medically treated group of the Veterans
Administration trial (35).
V. Atypical Chest Pain of Uncertain Origin
Atypical chest pain is defined as single or recurrent ep-
isodes of chest pain suggestive. but not typical, of the pain
of myocardial ischemia. The discomfort may have some
features of ischemic pain together with features of noncar-
diac pain. Chest pain that has no features of cardiac pain,
as well as typical chest pain of myocardial ischemia or
angina as determined by a careful medical history, is ex-
cluded from this definition.
Class I
I. Atypical chest pain when ECG or radionuclide stress
tests indicate that high risk coronary disease may be
present (see section IVA, Class Ia to Ic).
2. When the presence of atypical chest pain due to coro-
nary artery spasm is suspected.
3. When there are associated symptoms or signs of ab-
normal left ventricular function or failure.
Class II
I. Atypical chest pain when noninvasive studies are
equivocal or cannot be adequately performed.
2. When noninvasive tests are negative but symptoms
are severe and management requires that significant
coronary artery disease be excluded.
Class III
I. Atypical chest pain in patients without objective signs
of ischemia who have had an earlier technically sat-
isfactory normal coronary angiogram for the same
chest pain.
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Comments
In evaluating the patient with chest discomfort that is
atypical for myocardial ischemia, it should be emphasized
that coronary artery disease is predominantly a disease of
male patients until the seventh decade, when the incidence
of disease in female patients becomes equal to that in male
patients. The probability of disease in males is related to
age and other risk factors. For example, the likelihood of
coronary artery disease in a 45 year old man with atypical
chest pain is just under 50%. In contrast, coronary artery
disease in a premenopausal woman with atypical chest pain
is rare, unless multiple risk factors are present. In women
with atypical chest pain, an ischemic ST segment response
has poor predictive value for coronary heart disease (36).
Patients with chest pain that is clearly of noncardiac
origin generally do not require noninvasive studies to rule
out myocardial ischemia. Most ECG exercise studies will
either be negative or, if abnormal, will usually represent
false positive tests, especially in female patients (37-41).
VI. Acute Myocardial Infarction
The management of acute myocardial infarction is rapidly
changing. Therefore, indications for coronary angiography
and its timing after acute myocardial infarction are topics
of controversy and continue to change as experience evolves.
Acute infarction will be considered in three phases.
Evolving infarction encompasses the initial hours after the
onset of chest pain and is the period when intravenous or
intracoronary fibrinolytic therapy is increasingly used to
reduce mortality and the amount of tissue necrosis. The
phase of completed infarction begins after the initial hours
lasting up to, but not including, predischarge evaluation;
during this period a relatively small percentage of patients
suffer additional complications. The phase of convalescent
infarction is the ensuing period up to 8 weeks, when pre-
and postdischarge assessment, progressive ambulation and
rehabilitation take place.
Evolving Myocardial Infarction (initial hours of
myocardial infarction)
Class I
None
Class II
I. When coronary angiography can be performed within
the first 6 hours after the onset of chest pain in patients
who are candidates for revascularization therapy (per-
cutaneous transluminal angioplasty, coronary bypass
surgery or intracoronary thrombolysis).
2. After early intravenous thrombolytic therapy when im-
mediate percutaneous transluminal coronary angio-
plasty or coronary artery bypass grafting is being con-
templated.
Class III
None
Completed Myocardial Infarction (after the initial 6
hours up to but not including predischarge
evaluation)
Class I
I. Recurrent episodes of ischemic chest pain, particularly
if accompanied by ECG changes.
2. Suspected mitral regurgitation or ruptured interven-
tricular septum causing heart failure or shock.
3. Suspected subacute cardiac rupture (pseudoaneu-
rysm).
Class II
I. Thrombolytic therapy during the evolving phase, par-
ticularly with evidence of reperfusion.
2. Congestive heart failure or hypotension, or both, dur-
ing intensive medical therapy.
3. Recurrent ventricular tachycardia or ventricular fi-
brillation, or both, during intensive antiarrhythmic
therapy.
4. Cardiogenic shock.
5. When the infarction is suspected to be a consequence
of coronary embolization.
Class III
I. Myocardial infarction in which no acute mechanical
or surgical intervention is contemplated.
Convalescent Myocardial Infarction (immediate
predischarge up to 8 weeks)
Class I
I. Angina pectoris occurring at rest or with minimal ac-
tivity.
2. In selected patients, heart failure during the evolving
phase, or left ventricular ejection fraction <45%, pri-
marily when associated with some manifestation of
recurrent myocardial ischemia or with significant ven-
tricular arrhythmias.
3. Evidence of myocardial ischemia on laboratory test-
ing: exercise-induced ischemia (with or without ex-
ercise-induced angina pectoris), manifested by 2: I mm
of ischemic ST segment depression or exercise-in-
duced reversible thallium perfusion defect or defects,
or exercise-induced reduction in the ejection fraction
or wall motion abnormalities on radionuclide ventricu-
lographic studies.
4. Non-Q wave myocardial infarction.
Class II
I. Mild angina pectoris.
2. Asymptomatic status <50 years of age.
3. The need to return to unusually active and vigorous
physical employment.
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4. A past history of documented myocardial infarction
or stable angina pectoris, or both, present for >6
months before the current infarction.
5. Thrombolytic therapy during the evolving phase, par-
ticularly with evidence of reperfusion.
Class III
I. Presence of advanced physiologic age.
2. Coexisting disease judged to be primarily responsible
for the patient's prognosis, with a greatly shortened
life expectancy.
3. Presence of very advanced left ventricular dysfunction
(ejection fraction <20%) in the absence of angina
pectoris or evidence of ischemia. An exception is the
patient who is a candidate for aneurysmectomy or
cardiac transplantation.
4. Ventricular arrhythmias in patients who have no evi-
dence of ischemia symptomatically or on exercise test-
ing, well preserved exercise tolerance and no sugges-
tion of aneurysm formation. An exception may be the
patient with sustained, refractory ventricular tachy-
cardia.
Comments
Evolving myocardial infarction (initial hours)
Aggressive treatment of evolving myocardial infarction
is being increasingly utilized. This approach evolves from
several important developments related to coronary angi-
ography. First is the demonstration that coronary artery
thrombosis is present in a high percentage of patients studied
early after myocardial infarction (42). Second, coronary
angiography can be safely performed in patients with evolv-
ing infarction (43), and complex manipulations in coronary
arteries can be performed in a relatively rapid manner using
percutaneous transluminal coronary angioplasty techniques.
Third, coronary angiography has shown that effective re-
canalization is not achieved in a significant fraction of pa-
tients undergoing optimal intravenous thrombolytic therapy.
Finally, even with successful reperfusion using intravenous
or intracoronary thombolysis, a stenosis of ::::90% often is
present at the site of recanalization (44). In addition, data
from several large trials of thrombolysis have reported a
significant incidence of recurrent ischemia or infarction, or
both, after apparently successful thrombolysis alone (45-47).
These developments have led some to consider definitive
revascularization with early percutaneous transluminal coro-
nary angioplasty, or coronary artery bypass grafting, in ad-
dition to intracoronary thrombolytic therapy (44,46). These
invasive strategies may be used alone (48-50) or in com-
bination with thrombolysis, but all require coronary angi-
ography in the evolving stage of acute myocardial infarction.
Although there is still dispute concerning the precise role
of these aggressive treatments in managing evolving in-
farction, there is general agreement in several areas (51).
One is that the mortality of patients after acute myocardial
infarction, both early and late, is directly influenced by the
degree of left ventricular dysfunction which, in turn, is
dependent on the size of the infarcted myocardial region.
Accordingly, limiting the size of the infarction will lessen
the impact of myocardial infarction in terms of left ven-
tricular dysfunction and should improve subsequent sur-
vival. It is also agreed that the time interval between the
onset of abrupt coronary occlusion and institution of any
effective intervention should be relatively brief, probably
not more than 4 to 6 hours (47), and shorter when possible.
Finally, high grade residual stenosis limits the salvage of
tissue and impairs recovery of function (52). Therefore,
percutaneous transluminal coronary angioplasty initially or
early after thrombolysis may prove to be more effective than
thrombolysis alone in salvaging injured myocardium and
preserving ventricular function (46,52).
The major difficulty in employing early emergency coro-
nary angiography in the patient with evolving infarction as
a prelude to revascularization is logistic. Successful appli-
cation of this concept demands an adequate transport system
and a 24 hour emergency center staffed around the clock
with specialists in percutaneous transluminal coronary an-
gioplasty, cardiac catheterization and even cardiovascular
surgery. For these reasons, emergency coronary angiogra-
phy followed by acute revascularization is not a procedure
applicable to most patients with evolving myocardial in-
farction.
In some settings, coronary angiography relatively early
during acute myocardial infarction might be reserved for
those patients whose evolving infarction appears to involve
a substantial mass of myocardium, as judged by clinical
features (such as the presence of pulmonary congestion or
hypotension due to left ventricular dysfunction), with ex-
tensive electrocardiographic changes (usually anterior or an-
terolateral in location).
A number of newer fibrinolytic agents more clot specific
than streptokinase are undergoing clinical investigation in
the United States and abroad. These agents will likely be-
come widely used in the intravenous treatment of evolving
myocardial infarction and may be utilized as soon as the
diagnosis is established.
Completed myocardial infarction (6 hours up to predis-
charge workup)
The decision to perform coronary angiography at this
phase of acute myocardial infarction should be contingent
on an estimate of the short-term prognosis (days to several
weeks). If the prognosis is judged to be poor on the basis
of clinical, electrocardiographic and noninvasive estimates
of left ventricular function and continuing ischemia and it
is judged that outcome can be improved by urgent bypass
surgery or percutaneous transluminal angioplasty, then an-
giography is indicated.
The risks and complications of coronary bypass surgery
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appear to be greater in patients who have had a recent
transmural myocardial infarction and who have depressed
left ventricular function (53), so that it is preferable to allow
healing and compensatory changes to occur before pro-
ceeding with surgery. Hence, whenever possible, in such
patients coronary angiography as a prelude to bypass surgery
or percutaneous transluminal coronary angioplasty should
be postponed until the convalescent phase.
There is general agreement, however, that patients who
experience hemodynamic compromise or clinical heart fail-
ure with associated findings to suggest rupture of the intra-
ventricular septum, acute mitral regurgitation or pseudo-
aneurysm any time in the postinfarction period should undergo
prompt cardiac catheterization with appropriate angio-
graphic studies. Most such events occur within the first week
of the acute infarction. Over the past 5 years increasing
experience suggests that early surgical intervention for ven-
tricular septal rupture results in substantially improved sur-
vival; in a recent report of 20 consecutive patients undergo-
ing surgery within 2 days of the septal rupture, 60% survived
hospitalization (54), and the use of the intraaortic balloon
at the time of cardiac catheterization was considered to
reduce the complication rate found in earlier studies. The
primary information to be obtained from catheterization is
an estimation of left ventricular function and evaluation for
associated mitral insufficiency and determination of coro-
nary anatomy.
When unstable postinfarction angina pectoris develops
within the first week and remains refractory to medical ther-
apy, there is a 20% incidence of recurrent myocardial in-
farction or death during hospitalization (55). In addition, in
such patients others have shown a 25% mortality rate at 3
months (56) and a 50% mortality rate at 6 months (57).
Approximately 10 to 15% of patients with an acute myo-
cardial infarction will develop unstable angina within 7 days
(56); in those who fail to respond to intensive medical ther-
apy, coronary angiography with consideration of prompt
revascularization by angioplasty or coronary bypass surgery
is warranted.
Ongoing clinical trials are examining the efficacy and
appropriate timing for revascularization procedures (per-
cutaneous transluminal angioplasty, coronary bypass sur-
gery) after successful thrombolytic therapy, although it is
being performed with increasing frequency in the early days
after thrombolytic therapy.
There continues to be general agreement that patients
recovering from an acute myocardial infarction who are
clinically well and without symptoms should not be can-
didates for coronary angiography at this time merely to
delineate anatomy.
Convalescent myocardial infarction (from predischarge
workup to 8 weeks)
This group constitutes the largest segment of patients
with acute myocardial infarction considered for coronary
angiography. Depending on the character of the patient pop-
ulation and the nature of the hospital, a large majority of
patients with acute myocardial infarction will reach the con-
valescent phase of infarction without having undergone
coronary angiography. The principal indication for angiog-
raphy at this phase is to identify high risk patients for better
long-term management. Although an average mortality rate
of 6 to 10% for the first year after discharge following
recovery from myocardial infarction is usually cited, a num-
ber of the poor risk patients will have already undergone
coronary angiography if the criteria outlined in the sections
relating to evolving myocardial infarction and completed
infarction are used.
Management of the patient who has survived infarction
and reached convalescence without important complications
involves careful clinical judgment. Prognosis is best judged
on the basis of the history of ischemic heart disease before
the current infarction, the extent of left ventricular dys-
function and the presence of inducible myocardial ischemia.
A number of studies have shown increased mortality and
risk of recurrent infarction in patients with angina pectoris
or a positive exercise test (58-60), although there is a sig-
nificant incidence of false negative exercise tests in patients
with three vessel coronary disease relatively early after myo-
cardial infarction (61). Reduced ejection fraction at rest is
also an independent marker of increased risk (62,63), par-
ticularly when associated with signs or symptoms of left
ventricular failure at the time of hospitalization for acute
myocardial infarction (64). Frequent or complex ventricular
arrhythmias are an independent factor predicting increased
risk (62,65), particularly when associated with a low ejec-
tion fraction (62). The occurrence of non-Q wave myo-
cardial infarction carries an increased risk of reinfarction
and enhanced mortality (66,67). A variety of schemes ex-
tensively discussed in many publications help to place pa-
tients into risk categories (68). If the risk is judged to be
high, coronary angiography is indicated to determine whether
the patient is a candidate for bypass surgery or percutaneous
transluminal angioplasty.
Coronary angiography is frequently performed and may
be justifiable in young patients after myocardial infarction
because of the long-term morbidity that may follow another
infarction; nevertheless, the late morbidity is low in uncom-
plicated myocardial infarction in young patients and the
yield of multivessel disease on coronary angiography in such
patients also tends to be low (69).
VII. Valvular Heart Disease
Class I
I. When valve surgery is being considered in the adult
patient with chest discomfort or ECG changes, or both,
suggesting coronary artery disease.
2. When valve surgery is being considered in male pa-
tients 2':35 years of age.
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3. When valve surgery is being considered in female
patients who are postmenopausal.
Class II
I. During left heart catheterization when aortic or mitral
valve surgery is being considered in male patients <35
years of age.
2. During left heart catheterization when aortic or mitral
valve surgery is being considered in female patients
:::=:40 years of age.
3. When one or more major risk factors for coronary
artery disease are present (heavy smoking history, di-
abetes mellitus, hypertension, hyperlipidemia, strong
family history of premature coronary artery disease)
in adult patients of any age being considered for valve
surgery.
4. During left heart catheterization when reoperation for
aortic or mitral valve disease is being considered in
patients who have not had coronary angiography for
:::=: I year.
5. In the presence of infective endocarditis when there
is evidence for coronary embolization.
Class III
I. When cardiac surgical treatment is planned for infec-
tive endocarditis in patients who are <35 years of age
and have no evidence of coronary embolization.
2. When aortic or mitral valve surgery is being consid-
ered in female patients <40 years of age who have
no evidence suggesting coronary artery disease.
Comments
In patients undergoing operation for valvular heart dis-
ease there is evidence that the presence of significant coro-
nary artery disease not treated by coronary artery bypass
grafting at the time of valve surgery adversely affects out-
come (70). Surgical results in patients in whom valve re-
placement is combined with coronary artery bypass graft
surgery are now generally comparable with those in patients
having isolated valve replacement. Therefore, it is advisable
to combine bypass graft surgery with valve replacement
when these two conditions coexist.
In adult patients with aortic stenosis, there is general
agreement that a relatively high incidence (about 50%) of
coronary artery disease exists, in part because of the rela-
tively advanced average age of such patients. Angina pec-
toris is often associated with coronary artery disease in pa-
tients with aortic stenosis, but there is a significant incidence
(:::=:25%) of coronary artery disease in patients who do not
have angina pectoris (71). Moreover, some patients have
angina pectoris because of an imbalance between myo-
cardial oxygen demand and supply related to aortic valve
obstruction alone. There is no available technique other than
coronary angiography that allows identification of those pa-
tients with coronary artery disease.
There is a somewhat lower incidence of coronary artery
disease in patients with aortic regurgitation (approximately
30%), and a significant fraction of these patients do not have
angina pectoris (72). Coronary artery disease also occurs
with considerable frequency in mitral valve disease (23 to
50%), and angina pectoris is also an unreliable marker of
coronary artery disease in this setting. For example, in pa-
tients with mitral stenosis >40 years of age (average age
60 years), among the 28% of patients with significant coro-
nary artery disease angiographically, nearly two-thirds did
not have angina pectoris (73). It should be noted that in
older studies. >50% narrowing of the coronary arteries was
considered significant, whereas in more recent studies 70%
narrowing (or >50% narrowing of the left main artery) was
considered significant (71 ,73). Many past studies have rec-
ommended :::=:40 years as the age at which coronary angi-
ography should be carried out routinely before surgery for
valvular heart disease, although recently :::=:35 years has been
advocated for male patients (74).
In summary, combined valve replacement and coronary
bypass graft surgery is desirable in the patient with or with-
out angina pectoris if significant underlying obstructive
coronary artery disease is present. Therefore, in patients
being considered for valvular heart surgery who are at risk
for underlying coronary artery disease, investigation of the
coronary circulation is warranted. Thus, most adult male
patients and postmenopausal women should also have coro-
nary angiography performed at the time of cardiac cathe-
terization when valve replacement is being considered.
Infective endocarditis whether acute or subacute may
produce valvular insufficiency that requires valve replace-
ment. In some of these patients the endocarditis may result
in one or more major coronary emboli. This development
may result in the superimposition of the clinical picture of
acute myocardial infarction in a patient with c1earcut find-
ings of infective endocarditis. More commonly. it results
only in serial electrocardiographic evidence of Q wave or
non-Q wave myocardial infarction. If valve replacement is
being undertaken, it is desirable to evaluate the coronary
anatomy in such patients to determine whether one or more
proximal obstructive lesions are present that may warrant
concomitant bypass graft surgery.
VIII. Known or Suspected Congenital
Heart Disease
Class I
I. Evaluation of patients with congenital heart disease
who have signs or symptoms suggesting associated
atherosclerotic coronary artery disease.
2. Suspected congenital coronary anomalies such as con-
genital coronary artery stenosis, coronary arteriove-
nous fistula, supravalvular aortic stenosis and anom-
alous origin of left coronary artery, provided that
aortography is not diagnostic.
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3. When corrective open heart surgery for congenital
heart disease is being planned in male patients >40
years or postmenopausal female patients.
Class II
The presence of forms of congenital heart disease
frequently associated with coronary artery anomalies
that may complicate surgical management (including
tetralogy of Fallot, truncus arteriosus, transposition
complexes, corrected [levo] transposition), provided
that aortography is not diagnostic.
Class III
Coronary angiography is not routinely indicated in
the evaluation of congenital heart disease.
Comments
The rationale for coronary angiography in some patients
with congenital coronary lesions is similar to that for coro-
nary atherosclerosis, that is, to assess the severity of the
lesion and determine whether surgical treatment is indicated.
The principal anomalies in this group are congenital coro-
nary artery stenosis or atresia (75), coronary artery fistula
(75), anomalous left coronary artery arising from the pul-
monary artery (76) and anomalous left coronary artery aris-
ing from the right coronary artery or right sinus of Valsalva
and passing between the aorta and right ventricular outflow
tract (77). Unfortunately, the latter anomaly may present
with sudden death after exertion, without prior warning (78).
Other anomalies of position or origin of the coronary
arteries may cause no physiologic abnormality in them-
selves. Some, such as origin of the circumflex artery from
the right sinus of Valsalva, are not associated with other
congenital anomalies and present only as incidental findings
that complicate the performance and interpretation of coro-
nary angiograms. Others tend to occur with certain con-
genital anomalies, and because of anomalous position a
coronary artery may be injured at the time of surgical cor-
rection of the associated anomaly, so that preoperative coro-
nary angiography may be indicated. Most frequent in this
category is anomalous origin of the left anterior descending
coronary artery from the right coronary artery passing across
the anterior right ventricle in patients with tetralogy of Fallot
(79).
IX. Other Conditions
Class I
1. In diseases affecting the aorta when knowledge of the
presence or extent of coronary artery involvement is
necessary for management, (for example, the presence
of aortic aneurysm or ascending aortic dissection),
arteritis or homozygous type n hypercholesterolemia
in which coronary artery involvement is suspected.
The latter includes the presence of Kawasaki's disease
in patients who have angina and other evidence of
myocardial ischemia or infarction.
2. The presence of left ventricular failure without ob-
vious cause and adequate left ventricular systolic func-
tion (see section IYB, Class I, 4e).
3. When male patients who are 2':35 years of age or
female patients who are postmenopausal with hyper-
trophic cardiomyopathy have angina pectoris uncon-
trolled by medical therapy, or are to undergo surgery
for outflow tract obstruction.
Class II
I, The presence of dilated cardiomyopathy.
2. Recent blunt trauma to the chest and evidence of acute
myocardial infarction in patients who have no evi-
dence of preexisting coronary artery disease.
3, When male patients >35 years or postmenopausal
female patients are to undergo other cardiac surgical
procedures, such as pericardiectomy or removal of
chronic pulmonary emboli.
4. Prospective immediate cardiac transplant male donors
>35 or females >40 years of age.
5, Evaluation of asymptomatic patients with Kawasaki's
disease who have coronary artery aneurysms on echo-
cardiography.
Class III
None listed.
Comments
Most patients undergoing surgical treatment for aortic
dissection do not require coronary angiography before the
surgical procedure, However, in selected patients in whom
the dissection is believed to involve a coronary artery, or
in whom coronary artery disease is suspected, coronary
angiography may be helpful in determining the most ap-
propriate surgical approach. Patients with an aortic aneu-
rysm frequently have concomitant coronary artery disease
and may require coronary angiography before surgical cor-
rection of the aneurysm if they have evidence of myocardial
ischemia, are men >35 years or postmenopausal Women,
Some patients with inflammatory processes affecting the
aorta such as Takayasu's arteritis may have coronary artery
involvement requiring coronary artery revascularization. In
such patients, coronary angiography obviously is required
before the surgical procedure. Kawasaki's disease can result
in coronary artery aneurysm and coronary artery stenosis
producing myocardial ischemia or silent occlusion and may
require coronary angiographic assessment (80,81).
Significant coronary artery disease due to atherosclerosis
has been found in approximately 25% of patients >45 years
with hypertrophic cardiomyopathy who have undergone
coronary angiography (82). Because symptoms due to coro-
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nary artery disease and hypertrophic cardiomyopathy are
similar, male patients >35 years and postmenopausal fe-
male patients with ischemic symptoms not well controlled
with medical therapy may require coronary angiography.
Coronary angiography also is indicated in patients of this
age group with hypertrophic cardiomyopathy in whom a
surgical procedure to correct outflow tract obstruction is
planned.
The primary indications for coronary angiography in pa-
tients with a dilated form of cardiomyopathy are: I) during
consideration for cardiac transplantation and, 2) to differ-
entiate idiopathic dilated cardiomyopathy from ischemic
myocardial disease if the latter might be improved by re-
vascularization. The differentiation of patients with isch-
emic myocardial disease from those with the dilated type
of cardiomyopathy usually is not difficult because the great
majority of the former patients also have angina or evidence
of previous infarction (83). Furthermore, the management
of those with ischemic myocardial disease and severe gen-
eralized left ventricular dysfunction without angina gener-
ally is the same as that of patients with dilated cardio-
myopathy. Coronary angiography may be of value in those
patients with clinical findings suggesting dilated cardio-
myopathy who also have angina pectoris, left ventricular
aneurysm or evidence of reversible ischemia who might be
candidates for surgical revascularization if coronary artery
disease were present.
Patients who have an acute myocardial infarction shortly
after blunt chest trauma may have atherosclerotic coronary
artery disease, but coronary artery obstruction has been re-
ported in the absence of coronary atherosclerosis (84). Fur-
thermore, myocardial contusion may stimulate acute myo-
cardial infarction. Infrequently, coronary angiography is
indicated in the management of such patients.
In patients undergoing cardiac operations such as peri-
cardiectomy or removal of chronic pulmonary emboli (85),
perioperative coronary angiography may be indicated in the
coronary-prone age group.
Appendix A
I. Venous access is an important part of coronary angi-
ography. A well functioning intravenous infusion line
generally should be available before each procedure and
continued for a short period after its termination.
2. Hemodynamic assessment is a routine part of selective
coronary angiography. Before angiography, pressures
in the left ventricle and aorta are measured and, de-
pending on requirements in the individual patient, car-
diac output may be determined.
3. Left ventricular angiography is normally a routine part
of diagnostic selective coronary angiography, but may
be excluded in certain high risk patients if recent in-
formation on left ventricular function is available from
noninvasive studies. During left ventricular angiogra-
phy, contrast medium is injected into the left ventricular
cavity. From this visualization of the left ventricular
chamber, an assessment is made of left ventricular size,
global ventricular function (by calculating the ejection
fraction), regional wall motion, mitral regurgitation,
filling defects suggesting mural thrombus and so on.
Other techniques, such as intravenous digital angiog-
raphy or radionuclide angiography, are now also avail-
able in some centers to obtain this information.
4. Right heart catheterization is not routinely part of coro-
nary angiography but is an associated procedure in se-
lected patients. During right heart catheterization, in-
tracardiac pressures, oxygen content in blood samples,
dye-dilution curves and cardiac output may be obtained,
as well as right ventricular or pulmonary artery angi-
ography, or both, if needed. In situations in which right
ventricular function may be abnormal (right ventricular
infarction, tricuspid regurgitation, ventricular septal de-
fect), pulmonary artery disease is suspected (pulmonary
hypertension, pulmonary emboli) or heart failure is
present, right heart catheterization should be a part of
coronary angiography. Additionally, in patients with
unusual risk related to bradycardia or various degrees
of atrioventricular block, or in patients in unstable con-
dition, right heart catheterization with a pacing catheter
connected for standby pacing is an important safety
procedure to help ensure lower risk during coronary
angiography. Right heart catheterization also may be
indicated in certain other settings (for example, sus-
pected intracardiac shunt).
5. Selective internal mammary angiography usually is not
performed routinely preoperatively when use of the in-
ternal mammary arteries is planned. It may be done in
some patients when one of the internal mammary ar-
teries has been previously used, or when previous trau-
matic chest injury or thoracic surgery may have dam-
aged one of these vessels. It may also be done if
subclavian artery stenosis is suspected from the pres-
ence of a bruit or difference in blood pressure between
the two arms.
6. Selective saphenous vein bypass graft or internal mam-
mary artery angiography is done as an associated pro-
cedure in patiep.ts with previous coronary bypass sur-
gery.
7. Pharmacologic studies using ergonovine stress testing
and the response to orally or parenterally administered
nitroglycerin can be associated procedures used to iden-
tify the presence or absence of coronary artery spasm.
8. Aortic root angiography may be done to assess the ostia
of the coronary arteries in relation to the aortic root in
patients with suspected aortic aneurysm or dissection,
and also in patients with associated aortic valve incom-
petence to assess the degree of regurgitation. In patients
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with aortic stenosis, this associated procedure is some-
times useful in defining the size of the aortic anulus,
the origins of the coronary arteries or the presence of
supravalvular stenosis.
9. Digital subtraction angiography can be used to process
images of selectively injected coronary arteries. In ad-
dition, digital subtraction angiography can be used to
provide an assessment of carotid, femoral, renal or
peripheral arteries in selected patients at the time of
selective coronary angiography.
10. A number of transcatheter procedures for diagnosis or
therapy may be included as associated procedures when
there are indications for their use. These procedures
include percutaneous transluminal coronary angio-
plasty, intracoronary administration of thrombolytic
drugs, transcatheter ablation for arrhythmia control,
myocardial biopsy and others.
Appendix B
Grading of Angina of Effort by the Canadian
Cardiovascular Society*
I. "Ordinary physical activity does not cause . . . an-
gina ... ", such as walking and climbing stairs. An-
gina with strenuous or rapid or prolonged exertion at
work or recreation.
II. "Slight limitation of ordinary activity." Walking or
climbing stairs rapidly, walking uphill, walking or stair
climbing after meals, or in cold, or in wind, or under
emotional stress or only during the few hours after
awakening. Walking more than two blocks on the level
and climbing more than one flight of ordinary stairs at
a normal pace and in normal conditions.
III. "Marked limitation of ordinary physical activity."
Walking one to two blocks on the level and climbing
one flight of stairs in normal conditions and at normal
pace.
IV. "Inability to carryon any physical activity without
discomfort-anginal syndrome may be present at rest. "
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